{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-274383","form_type":"8-K","ticker":"LXRX","cik":"0001062822","company_name":"LEXICON PHARMACEUTICALS, INC.","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.696040+00:00","generated_at":"2026-05-16T22:12:11.544631+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Lexicon corrects prospectus error on EY internal control audit exemption","bullets":["Prospectus supplement inadvertently stated EY audited internal controls as of Dec 31, 2024.","As a smaller reporting company/non-accelerated filer, Lexicon is exempt from such audit; EY did not perform it.","Correction relates to existing $75M at-the-market equity facility with Jefferies LLC.","No impact on financial statements or current business operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-274383","json":"https://secwatch.observer/filing/0001193125-25-274383.json","markdown":"https://secwatch.observer/filing/0001193125-25-274383.md","text":"https://secwatch.observer/filing/0001193125-25-274383.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1062822/000119312525274383/0001193125-25-274383-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1062822/000119312525274383/d30705d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:12:11.544631+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}